Egyptian Drug Authority signs a new agreement to develop medical personnel in Egypt
The activities of the fifth edition of the Africa Health ExCon 2026 witnessed an important step towards strengthening the health sector in Egypt. The Egyptian Drug Authority signed a new cooperation protocol with GlaxoSmithKline Egypt, aiming to improve the level of pharmaceutical services.
This cooperation focuses primarily on developing the skills of workers in the pharmaceutical sector. The agreement includes specialized training programs aimed at raising the efficiency of pharmacists and health professionals, which contributes to providing better medical care for Egyptian citizens.
Through this partnership, the Drug Authority seeks to keep pace with the latest global standards in the field of pharmaceutical manufacturing and regulation. The protocol also aims to exchange scientific and technical expertise between the Authority and the company, supporting the state's strategy to localize the pharmaceutical industry.
This event comes within the framework of Egypt's continuous efforts to become a regional hub for healthcare in Africa. Officials emphasize that investing in professional training is the cornerstone for ensuring the quality of medicines and patient safety across the country.
In conclusion, this agreement reflects the importance of the partnership between the public and private sectors in developing the health system. It is expected that the results of this cooperation will appear in a tangible improvement in the pharmaceutical services available to citizens in the coming period.